What happens when university research shows that a technology can help people, but there isn't yet a company capable of bringing it to market? That's one of the questions at the heart of InrobicsThe founders of Inrobics.
In a new interview conducted by StartupxploreThe three founders of the company, José Carlos Pulido, CEO; José Carlos González, CTO; and Fernando Fernández, CSO, tell how two doctoral theses and more than a decade of research in social robotics and artificial intelligence ended up becoming a business project.
Conversation allows us to get to know each other. Inrobics from the perspective of those who made the decision to take the technology out of the laboratory and transfer it to hospitals, social and healthcare centers, schools and homes.
A conversation about the origin of Inrobics
Before our products, deployments, or current team existed, there was a line of research and a shared question: could social robotics become a useful tool for professionals and for people who need rehabilitation, stimulation, or companionship?
During their doctoral theses, José Carlos Pulido and José Carlos González worked on the development of interaction systems between people and social robots. Fernando Fernández, director of both research projects, was also a key figure in ensuring that this knowledge did not remain solely within publications and prototypes.
In the interview, the founders explain how the decision to start a business arose and what it meant to create a company around a technology that, at that time, was still little known and barely present in health and care environments.
It wasn't just about building a technically advanced solution. It was also about ensuring that professionals trusted it, that it was easy to use, and that it delivered value in real-world contexts.
To start a business with a technology that didn't yet have a market
One of the most interesting aspects of the interview is the reflection on what it means to start a business when technology is ahead of general market knowledge.
In the early years of Inrobics It wasn't enough to explain the functionalities of a robot or an artificial intelligence system. It was necessary to introduce a new way of understanding the interaction between people and technology.
Social robotics needed to stop being perceived as something distant, experimental, or confined to a laboratory. It had to demonstrate that it could be integrated as a tool at the service of therapists, healthcare professionals, educators, and caregivers.
This process has required years of research, clinical validation, technological development, and direct collaboration with the centers and professionals who use the solutions.
The full interview can be viewed here:
The experience of building something that didn't exist before.
Starting a business with a new technology requires moving forward without many references.
The founders of Inrobics They have had to develop the product, explain an emerging market, overcome regulatory barriers, generate evidence, listen to professionals, and build a business model around an innovation born in the university.
The interview reveals the technological and business aspects of that journey, but also its personal dimension.
It speaks of uncertainty, learning, commitment, and the need to believe in a vision long enough for other people to begin to see it too.
Today Inrobics It has a multidisciplinary team, its own technology, a certified medical device, and solutions deployed in real-world environments.
But the purpose remains the same as when the project began: to make artificial intelligence and social robotics useful tools for people and those who care for them.
Discover the investment opportunity in Inrobics
The investment round of Inrobics It remains open through Startupxplore.
The opportunity page provides more detailed information on the business model, the company's evolution, traction data, the team, growth objectives, and documentation related to the transaction.
Check out the investment opportunity in Inrobics here.
